These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 32084592)

  • 1. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study.
    Kravvariti E; Koutsogianni A; Samoli E; Sfikakis PP; Tektonidou MG
    Autoimmun Rev; 2020 Apr; 19(4):102491. PubMed ID: 32084592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
    Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
    Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.
    Erkan D; Unlu O; Sciascia S; Belmont HM; Branch DW; Cuadrado MJ; Gonzalez E; Knight JS; Uthman I; Willis R; Zhang Z; Wahl D; Zuily S; Tektonidou MG;
    Lupus; 2018 Mar; 27(3):399-406. PubMed ID: 28764618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.
    Rand JH; Wu XX; Quinn AS; Chen PP; Hathcock JJ; Taatjes DJ
    Blood; 2008 Sep; 112(5):1687-95. PubMed ID: 18577708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome.
    Belizna C
    Autoimmun Rev; 2015 Apr; 14(4):358-62. PubMed ID: 25534016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
    de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E
    Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus.
    Broder A; Putterman C
    J Rheumatol; 2013 Jan; 40(1):30-3. PubMed ID: 22859353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.
    Yelnik CM; Urbanski G; Drumez E; Sobanski V; Maillard H; Lanteri A; Morell-Dubois S; Caron C; Dubucquoi S; Launay D; Duhamel A; Hachulla E; Hatron PY; Lambert M
    Lupus; 2017 Feb; 26(2):163-169. PubMed ID: 27432808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome.
    Arachchillage DJ; Laffan M; Pericleous C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
    Kato M; Hisada R; Atsumi T
    Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?
    Zuo Y; Barbhaiya M; Erkan D
    Curr Rheumatol Rep; 2018 Sep; 20(11):66. PubMed ID: 30203272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological evolution in women with positive antiphospholipid antibodies.
    Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
    Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies.
    Marchetti T; Ruffatti A; Wuillemin C; de Moerloose P; Cohen M
    J Thromb Haemost; 2014 Jun; 12(6):910-20. PubMed ID: 24656088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.
    Albert CR; Schlesinger WJ; Viall CA; Mulla MJ; Brosens JJ; Chamley LW; Abrahams VM
    Am J Reprod Immunol; 2014 Feb; 71(2):154-64. PubMed ID: 24325143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
    Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
    JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
    Sciascia S; Branch DW; Levy RA; Middeldorp S; Pavord S; Roccatello D; Ruiz-Irastorza G; Tincani A; Khamashta M; Schreiber K; Hunt BJ
    Thromb Haemost; 2016 Jan; 115(2):285-90. PubMed ID: 26421409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the clinical significance of longitudinal antiphospholipid antibody titers.
    Chighizola CB; Willis R; Maioli G; Sciascia S; Andreoli L; Amengual O; Radin M; Gerosa M; Atsumi T; de Jesus G; Trespidi L; Branch DW; Caporali R; Andrade D; Roubey R; Petri M; Bertolaccini ML
    Autoimmun Rev; 2024 Mar; 23(3):103510. PubMed ID: 38171447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
    Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
    J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.